Bone marrow transplantation reduces FGF-23 levels and restores bone formation in myelodysplastic neoplasms

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

Heike Weidner - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)
Ulrike Baschant - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)
Maria G Ledesma-Colunga - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)
Karolina Basiak - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)
Elena Tsourdi - , University Hospital Carl Gustav Carus Dresden (Author)
Katja Sockel - , Department of Internal Medicine I, National Center for Tumor Diseases (NCT) Dresden (Author)
Katharina S Götze - , Bavarian Center for Cancer Research (BZKF) (Author)
Jennifer Rivière - , Technical University of Munich (Author)
Uwe Platzbecker - , Department of Internal Medicine I, University Hospital Leipzig, German Cancer Consortium (DKTK) Partner Site Dresden, German Cancer Consortium (DKTK) partner site Munich, German Cancer Research Center (DKFZ) (Author)
Lorenz C Hofbauer - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, German Cancer Consortium (DKTK) Partner Site Dresden, German Cancer Consortium (DKTK) partner site Munich, German Cancer Research Center (DKFZ) (Author)
Martina Rauner - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)

Humans, Myelodysplastic Syndromes/therapy, Fibroblast Growth Factor-23, Fibroblast Growth Factors/metabolism, Bone Marrow Transplantation/methods, Osteogenesis, Male, Female, Middle Aged, Aged